Data gathered: April 15
Alternative Data for Soleno Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 7 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 15,000 | Sign up | Sign up | Sign up |
| Google Trends | 20 | Sign up | Sign up | Sign up |
| Patents | 9 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 12 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,060 | Sign up | Sign up | Sign up |
| Twitter Mentions | 25 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 106 | Sign up | Sign up | Sign up |
About Soleno Therapeutics
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
| Price | $70.00 |
| Target Price | Sign up |
| Volume | 1,080,000 |
| Market Cap | $3.08B |
| Year Range | $42.54 - $73.67 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Soleno Therapeutics announces VYKAT XR launchApril 14 - Thefly.com |
Soleno Therapeutics Announces VYKAT(TM) XR LaunchApril 14 - GlobeNewswire |
|
 |
What is HC Wainwright’s Forecast for SLNO Q1 Earnings?April 4 - ETF Daily News |
|
Soleno Therapeutics (NASDAQ:SLNO) Shares Down 6.7% on Insider SellingApril 2 - ETF Daily News |
|
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $94.57 Consensus PT from BrokeragesApril 2 - ETF Daily News |
|
Soleno Therapeutics (NASDAQ:SLNO) Stock Price Expected to Rise, HC Wainwright Analyst SaysApril 2 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 49M | -49M | -77M | -80M | -1.830 |
| Q2 '24 | 0 | 11M | -11M | -22M | -24M | -0.570 |
| Q1 '24 | 0 | 9M | -9M | -21M | -23M | -0.590 |
| Q4 '23 | 3.4M | 4.6M | -4.6M | -11M | -13M | -0.330 |
| Q3 '23 | 0 | 3.3M | -3.3M | -11M | -9.9M | -0.950 |
Insider Transactions View All
| Hirano Patricia C filed to sell 27,036 shares at $70.1. April 2 '25 |
| Hirano Patricia C filed to sell 30,818 shares at $73.6. March 31 '25 |
| Hirano Patricia C filed to sell 55,086 shares at $67.5. March 31 '25 |
| Hirano Patricia C filed to sell 33,509 shares at $69.5. March 31 '25 |
| Pauls Matthew filed to sell 6,500 shares at $71.6. March 31 '25 |
Similar companies
Read more about Soleno Therapeutics (SLNO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Soleno Therapeutics?
The Market Cap of Soleno Therapeutics is $3.08B.
What is the current stock price of Soleno Therapeutics?
Currently, the price of one share of Soleno Therapeutics stock is $70.00.
How can I analyze the SLNO stock price chart for investment decisions?
The SLNO stock price chart above provides a comprehensive visual representation of Soleno Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Soleno Therapeutics shares. Our platform offers an up-to-date SLNO stock price chart, along with technical data analysis and alternative data insights.
Does SLNO offer dividends to its shareholders?
As of our latest update, Soleno Therapeutics (SLNO) does not offer dividends to its shareholders. Investors interested in Soleno Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Soleno Therapeutics?
Some of the similar stocks of Soleno Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.